论文部分内容阅读
目的:对痰热清注射液与利巴韦林治疗上呼吸道感染的疗效进行分析比较,分析呼吸道感染治疗中痰热清注射液的疗效。方法:选取本院2011年1月-12月期间收治的100例上呼吸道感染患者作为研究对象,随机、平均分为观察组与对照组,两组患者在年龄、性别等方面差异不具统计学意义。观察组运用痰热清注射液进行治疗,剂量为0.6ml/(kg.d),以5%的葡萄糖注射液250ml每天1次静脉滴注;对照组运用利巴韦林注射液进行治疗,剂量为0.5g/次,以5%的葡萄糖注射液250ml,每天2次静脉滴注,对两组患者的治疗效果进行对比分析。结果:在两组的治疗效果方面,观察组有效率高达98%,对照组有效率为72%,两组有效率具有明显差异,差异有统计学意义(P<0.05)。观察组有29例患者实施治疗72h之内发热退至正常,食欲提高,精神状态明显改善,病症痊愈,所占比例为58%,对照仅有19例,所占比例为38%,两组患者72h内痊愈率具有明显差异,差异具有统计学意义(P<0.05)。结论:在上呼吸道感染患者的治疗中,痰热清注射液具有退热、止咳、祛痰等疗效,且起效时间更短,安全性更高,具有临床推广价值。
Objective: To analyze and compare the curative effect of Tanreqing injection and ribavirin in the treatment of upper respiratory tract infection, and to analyze the curative effect of Tanreqing injection in treating respiratory tract infection. Methods: A total of 100 patients with upper respiratory tract infection admitted to our hospital from January to December in 2011 were randomly divided into observation group and control group. There was no significant difference in age and gender between the two groups . The observation group was treated with Tanreqing Injection at a dose of 0.6ml / (kg · d) with 250ml of 5% dextrose injection once daily. The control group was treated with ribavirin injection. The dose 0.5g / time to 5% glucose injection 250ml, 2 times a day intravenous infusion, the two groups of patients treated with comparative analysis. Results: In the two groups, the effective rate was 98% in the observation group and 72% in the control group, with significant differences between the two groups (P <0.05). In the observation group, 29 patients returned to normal within 72 hours after treatment. The appetite was improved and the mental state was significantly improved. The illness recovered, accounting for 58% of the patients in the observation group and only 19 cases of the control group, accounting for 38% of the patients in the observation group. The two groups of patients 72h recovery rate was significantly different, the difference was statistically significant (P <0.05). Conclusion: In the treatment of patients with upper respiratory tract infection, Tanreqing injection has antipyretic, antitussive and expectorant effects, and its onset time is shorter and more safe, and has clinical value of popularization.